Excellent visual outcomes in cataract surgery

Article

Cataract surgery produces excellent visual outcomes, with 61.3% of patients achieving a corrected distance visual acuity of 20/20 or better, according to a database study in the Journal of Cataract and Refractive Surgery.

Cataract surgery produces excellent visual outcomes, with 61.3% of patients achieving a corrected distance visual acuity of 20/20 or better, according to a database study in the Journal of Cataract and Refractive Surgery.

Dr Mats Lundström and his team, Department Ophthalmology, Faculty of Medicine, Lund University, Lund, Sweden, included data on 368,256 cataract extractions from 15 cataract surgery clinics in Europe. The data consisted of individual anonymous data on preoperative, intraoperative and postoperative measurements.

The best visual outcome was seen in age groups 40 to 74 years and men presented a higher percentage of excellent vision. Corrected distance visual acuity (CDVA) of 20/40 or better was achieved in 94.3% and 20/20 or better was obtained in 61.3% of patients.

Overall, the factors that greatly affected visual outcomes were ocular comorbidity and postoperative complications. Also, surgical complications and ocular changes that needed complex surgery also negatively affected outcomes.

The abstract can be viewed here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.